开云app官网登录入口网页版-官方正版

#卫材#

44篇内容 | 1808人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1447952, encodeId=35f4144e95288, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=卫材与百时美施贵宝在ADC药物达成或高达30亿美元战略合作协议, objectType=article, longId=212888, objectId=cecd21288851, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cecd21288851, replyNumber=0, likeNumber=97, createdTime=2021-06-20, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cecd21288851, moduleTitle=卫材与百时美施贵宝在ADC药物达成或高达30亿美元战略合作协议, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=cecd21288851)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447951, encodeId=e413144e951bc, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=国家药监局批准卫材仑伐替尼治疗甲状腺癌，这是第二个适应症, objectType=article, longId=203201, objectId=fb9120320195, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb9120320195, replyNumber=0, likeNumber=75, createdTime=2020-11-11, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb9120320195, moduleTitle=国家药监局批准卫材仑伐替尼治疗甲状腺癌，这是第二个适应症, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fb9120320195)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447950, encodeId=593d144e95045, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=卫材在日本推出新型抗失眠药Dayvigo（lemborexant）, objectType=article, longId=197186, objectId=ec5319e186eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ec5319e186eb, replyNumber=0, likeNumber=96, createdTime=2020-07-09, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ec5319e186eb, moduleTitle=卫材在日本推出新型抗失眠药Dayvigo（lemborexant）, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ec5319e186eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447949, encodeId=06aa144e94940, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=吉利德与卫材达成协议：在日本共同推广非洛替尼（Filgotinib）治疗类风湿性关节炎, objectType=article, longId=185338, objectId=b9ff1853386c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b9ff1853386c, replyNumber=0, likeNumber=73, createdTime=2019-12-29, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b9ff1853386c, moduleTitle=吉利德与卫材达成协议：在日本共同推广非洛替尼（Filgotinib）治疗类风湿性关节炎, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=b9ff1853386c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447948, encodeId=975a144e9482c, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=失眠症治疗迎来曙光：FDA已批准卫材的Dayvigo, objectType=article, longId=185145, objectId=26df1851459f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=26df1851459f, replyNumber=0, likeNumber=76, createdTime=2019-12-26, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=26df1851459f, moduleTitle=失眠症治疗迎来曙光：FDA已批准卫材的Dayvigo, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=26df1851459f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447947, encodeId=1db0144e94751, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=卫材阿尔兹海默症新药BAN2401在中国获批临床, objectType=article, longId=182806, objectId=d2201828061d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2201828061d, replyNumber=0, likeNumber=82, createdTime=2019-11-12, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2201828061d, moduleTitle=卫材阿尔兹海默症新药BAN2401在中国获批临床, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d2201828061d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447946, encodeId=dc36144e94630, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=大逆转，曾终止临床三期的AD药物aducanumab将申请上市昨日（10月22日），渤健（Biogen）和卫材（Eisai）联合宣布，在与美国FDA沟通后，渤健, objectType=article, longId=181821, objectId=ade018182134, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ade018182134, replyNumber=0, likeNumber=109, createdTime=2019-10-25, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ade018182134, moduleTitle=大逆转，曾终止临床三期的AD药物aducanumab将申请上市昨日（10月22日），渤健（Biogen）和卫材（Eisai）联合宣布，在与美国FDA沟通后，渤健, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=ade018182134)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447945, encodeId=8b0d144e9459e, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=卫材中国积极参与“第二届阿尔茨海默病月记忆健步行大型倡导活动”, objectType=article, longId=181519, objectId=99ba181519c2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99ba181519c2, replyNumber=0, likeNumber=113, createdTime=2019-10-19, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99ba181519c2, moduleTitle=卫材中国积极参与“第二届阿尔茨海默病月记忆健步行大型倡导活动”, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=99ba181519c2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447944, encodeId=e2d3144e944a1, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=卫材Halaven获NMPA批准用于治疗局部晚期或转移性乳腺癌, objectType=article, longId=175757, objectId=e12a1e575723, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e12a1e575723, replyNumber=0, likeNumber=78, createdTime=2019-07-20, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e12a1e575723, moduleTitle=卫材Halaven获NMPA批准用于治疗局部晚期或转移性乳腺癌, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e12a1e575723)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447943, encodeId=2895144e94399, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=卫材（中国）药业再捐35万元帮助认知障碍老人回家, objectType=article, longId=174874, objectId=59991e487488, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=59991e487488, replyNumber=0, likeNumber=99, createdTime=2019-07-06, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=59991e487488, moduleTitle=卫材（中国）药业再捐35万元帮助认知障碍老人回家, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=59991e487488)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447942, encodeId=672c144e9421b, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=卫材中国区总经理冯艳辉女士：将患者及家属的利益放在首位, objectType=article, longId=167793, objectId=e4f516e79376, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e4f516e79376, replyNumber=0, likeNumber=96, createdTime=2019-06-08, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e4f516e79376, moduleTitle=卫材中国区总经理冯艳辉女士：将患者及家属的利益放在首位, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=e4f516e79376)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447941, encodeId=8de3144e94153, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=卫材中国奖.助学金迎来新合作院校：中国药科大学药学院, objectType=article, longId=167791, objectId=5ff816e7911c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5ff816e7911c, replyNumber=0, likeNumber=108, createdTime=2019-06-08, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5ff816e7911c, moduleTitle=卫材中国奖.助学金迎来新合作院校：中国药科大学药学院, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=5ff816e7911c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447940, encodeId=a036144e94006, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=卫材中国持续助力5.9无走失日, objectType=article, longId=166165, objectId=818116616537, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=818116616537, replyNumber=0, likeNumber=78, createdTime=2019-05-17, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=818116616537, moduleTitle=卫材中国持续助力5.9无走失日, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=818116616537)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447939, encodeId=5aa2144e939cf, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=关于卫材（苏州）贸易作为ICG设备**进口商和销售商的声明, objectType=article, longId=161810, objectId=d2b716181010, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2b716181010, replyNumber=0, likeNumber=65, createdTime=2019-03-08, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2b716181010, moduleTitle=关于卫材（苏州）贸易作为ICG设备**进口商和销售商的声明, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d2b716181010)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447938, encodeId=80e6144e938c7, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=“2019卫材中国神经科学高峰论坛”在沪顺利召开, objectType=article, longId=161652, objectId=fa29161652ec, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fa29161652ec, replyNumber=0, likeNumber=73, createdTime=2019-03-06, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fa29161652ec, moduleTitle=“2019卫材中国神经科学高峰论坛”在沪顺利召开, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=fa29161652ec)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447937, encodeId=692e144e937e0, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=第五届卫材中国GIVE消化疾病诊疗论坛在杭州成功举办, objectType=article, longId=161651, objectId=3a1d1616519c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3a1d1616519c, replyNumber=0, likeNumber=103, createdTime=2019-03-06, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3a1d1616519c, moduleTitle=第五届卫材中国GIVE消化疾病诊疗论坛在杭州成功举办, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=3a1d1616519c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447936, encodeId=473b144e93617, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=卫材第四次入选全球更佳可持续发展企业百强, objectType=article, longId=158846, objectId=56ab15884631, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=56ab15884631, replyNumber=0, likeNumber=96, createdTime=2019-01-26, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=56ab15884631, moduleTitle=卫材第四次入选全球更佳可持续发展企业百强, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=56ab15884631)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447935, encodeId=de6b144e93519, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=卫材中国和默沙东中国共同举办仑伐替尼中国上市会, objectType=article, longId=158213, objectId=18091582130e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=18091582130e, replyNumber=0, likeNumber=112, createdTime=2019-01-18, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=18091582130e, moduleTitle=卫材中国和默沙东中国共同举办仑伐替尼中国上市会, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=18091582130e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447934, encodeId=7948144e934b2, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=卫材乐卫玛荣膺“2018年度十大创新药物, objectType=article, longId=157791, objectId=066615e79102, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=066615e79102, replyNumber=0, likeNumber=112, createdTime=2019-01-12, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=066615e79102, moduleTitle=卫材乐卫玛荣膺“2018年度十大创新药物, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=066615e79102)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1447933, encodeId=1ca6144e93342, content=<a href='/topic/show?id=72233658193' target=_blank style='color:#2F92EE;'>#卫材#</a>, objectTitle=50名川大华西临床医学院和华西药学院学生获颁卫材中国奖助学金, objectType=article, longId=156939, objectId=d9eb15693926, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d9eb15693926, replyNumber=0, likeNumber=68, createdTime=2018-12-30, rootId=0, userName=yyanpro@23cn.c, userId=de215370353, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d9eb15693926, moduleTitle=50名川大华西临床医学院和华西药学院学生获颁卫材中国奖助学金, moduleType=article, hrefUrl=//m.sandwebs.com/article/show_article.do?id=d9eb15693926)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 风湿免疫小助手

卫材

2020-05-29

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

卫材与百时美施贵宝在ADC药物达成或高达30亿美元战略合作协议

2021-06-20

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

国家药监局批准卫材仑伐替尼治疗甲状腺癌，这是第二个适应症

2020-11-11

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

卫材在日本推出新型抗失眠药Dayvigo（lemborexant）

2020-07-09

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

吉利德与卫材达成协议：在日本共同推广非洛替尼（Filgotinib）治疗类风湿性关节炎

2019-12-29

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

失眠症治疗迎来曙光：FDA已批准卫材的Dayvigo

2019-12-26

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

卫材阿尔兹海默症新药BAN2401在中国获批临床

2019-11-12

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

大逆转，曾终止临床三期的AD药物aducanumab将申请上市昨日（10月22日），渤健（Biogen）和卫材（Eisai）联合宣布，在与美国FDA沟通后，渤健

2019-10-25

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

卫材中国积极参与“第二届阿尔茨海默病月记忆健步行大型倡导活动”

2019-10-19

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

卫材Halaven获NMPA批准用于治疗局部晚期或转移性乳腺癌

2019-07-20

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

卫材（中国）药业再捐35万元帮助认知障碍老人回家

2019-07-06

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

卫材中国区总经理冯艳辉女士：将患者及家属的利益放在首位

2019-06-08

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

卫材中国奖.助学金迎来新合作院校：中国药科大学药学院

2019-06-08

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

卫材中国持续助力5.9无走失日

2019-05-17

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

关于卫材（苏州）贸易作为ICG设备**进口商和销售商的声明

2019-03-08

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

“2019卫材中国神经科学高峰论坛”在沪顺利召开

2019-03-06

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

第五届卫材中国GIVE消化疾病诊疗论坛在杭州成功举办

2019-03-06

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

卫材第四次入选全球更佳可持续发展企业百强

2019-01-26

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

卫材中国和默沙东中国共同举办仑伐替尼中国上市会

2019-01-18

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

卫材乐卫玛荣膺“2018年度十大创新药物

2019-01-12

yyanpro@23cn.c (审核中...)

前往app查看评论内容

#卫材#

50名川大华西临床医学院和华西药学院学生获颁卫材中国奖助学金

2018-12-30

科室
- - 订阅+
  - 更多科室
工具
服务